Overview
Clinical Meaning
Liver function tests (LFTs) comprise a panel of serum biomarkers that reflect hepatocellular integrity, biliary function, and synthetic capacity of the liver.
Liver function tests (LFTs) comprise a panel of serum biomarkers that reflect hepatocellular integrity, biliary function, and synthetic capacity of the liver. Understanding the patterns of elevation guides the NP toward accurate differential diagnosis and appropriate workup. Hepatocellular enzymes: Alanine aminotransferase (ALT) is predominantly found in hepatocytes and is the most specific marker of hepatocellular injury. Aspartate aminotransferase (AST) is found in hepatocytes, cardiac muscle, skeletal muscle, kidney, and brain, making it less liver-specific. Both are released into the serum when hepatocyte membranes are damaged. The AST:ALT ratio provides diagnostic information: ratio <1 in most hepatitis (viral, drug-induced); ratio >2:1 strongly suggests alcoholic liver disease (alcohol preferentially damages mitochondria where AST is concentrated, and chronic alcohol use depletes pyridoxal-5-phosphate [vitamin B6] needed for ALT synthesis); ratio >3:1 is highly suggestive of alcoholic hepatitis. Cholestatic enzymes: Alkaline phosphatase (ALP) is present in bile duct epithelium, bone, placenta, and intestine. Gamma-glutamyl transferase (GGT) is found in bile duct epithelium and hepatocytes. Elevation of both ALP and GGT together indicates hepatobiliary origin (cholestatic pattern). Isolated ALP elevation without GGT elevation suggests bone origin...